Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.79 CAD | -1.19% | -1.36% | +11.56% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
Sales 2024 * | 345M 250M | Sales 2025 * | 354M 257M | Capitalization | 586M 425M |
---|---|---|---|---|---|
Net income 2024 * | 3M 2.17M | Net income 2025 * | 2M 1.45M | EV / Sales 2024 * | 1.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.65 x |
P/E ratio 2024 * |
64.3
x | P/E ratio 2025 * |
59.4
x | Employees | 725 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.55% |
Latest transcript on Knight Therapeutics Inc.
1 day | -1.19% | ||
1 week | -1.36% | ||
Current month | +9.25% | ||
1 month | +7.62% | ||
3 months | +2.12% | ||
6 months | +28.10% | ||
Current year | +11.56% |
Managers | Title | Age | Since |
---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 55 | 13-10-31 |
Jonathan Goodman
FOU | Founder | 56 | 13-10-31 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 16-06-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 14-01-05 |
Jonathan Goodman
FOU | Founder | 56 | 13-10-31 |
Robert N. Lande
BRD | Director/Board Member | 61 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 11 M€ | -.--% | ||
0.01% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 5.79 | -1.19% | 75,589 |
24-04-17 | 5.86 | +1.56% | 59,023 |
24-04-16 | 5.77 | +0.17% | 56,114 |
24-04-15 | 5.76 | +1.05% | 69,390 |
24-04-12 | 5.7 | -2.90% | 51,466 |
Delayed Quote Toronto S.E., April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.56% | 429M | |
+9.64% | 9.08B | |
-15.94% | 4.57B | |
+18.47% | 3.9B | |
+1.89% | 3.69B | |
+28.61% | 2.62B | |
-24.63% | 2.34B | |
-29.37% | 2.14B | |
+2.55% | 1.84B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- GUD Stock